Park Ka Hyon, Park Yoonkyung, Park Ii-Seon, Hahm Kyung-Soo, Shin Song Yub
Department of Bio-Materials, Graduate School and Research Center for Proteineous Materials, Chosun University, Gwangju, Korea.
J Pept Sci. 2008 Jul;14(7):876-82. doi: 10.1002/psc.1019.
To develop novel Pro-rich model AMPs with shorter length and higher bacterial selectivity/therapeutic index (TI) than natural AMP, indolicidin, we synthesized a series of undodecapeptides derived from the sequence XXPXXPWXPXX-NH2 (X indicates Leu or Lys) with different ratios of Lys and Leu residues. Several Pro-rich model peptides (K7 WP3, K6 WL1 P3, K5 WL2 P3-1, K5 WL2 P3-2, and K4 WL3 P3) had approximate 8- to 11-fold higher bacterial selectivity/TI compared to indolicidin. These peptides selectively bind to negatively charged liposomes (EYPG/EYPG; 7:3, w/w) mimicking bacterial membranes. Their high selectivity to negatively charged phospholipids corresponds well with their high bacterial selectivity. Indolicidin showed almost complete depolarization of the cytoplasmic membrane of Staphylococcus aureus and dye-leakage from negatively charged liposomes at 10 microM, whereas all of Pro-rich model peptides had very little activity in these assays even at 80 microM, as observed in buforin 2. These results suggest that the ultimate target of our designed Pro-rich model peptides is probably the intracellular components (e.g. protein, DNA or RNA) rather than the cytoplasmic membranes. Collectively, our designed Pro-rich short model peptides appear to be excellent candidates for future development as a novel antimicrobial agent.
为了开发出比天然抗菌肽吲哚杀菌素长度更短、细菌选择性/治疗指数(TI)更高的富含脯氨酸的新型模型抗菌肽,我们合成了一系列由序列XXPXXPWXPXX-NH2(X表示亮氨酸或赖氨酸)衍生而来的十二肽,其中赖氨酸和亮氨酸残基的比例各不相同。与吲哚杀菌素相比,几种富含脯氨酸的模型肽(K7 WP3、K6 WL1 P3、K5 WL2 P3-1、K5 WL2 P3-2和K4 WL3 P3)的细菌选择性/TI大约高8至11倍。这些肽选择性地结合模拟细菌膜的带负电荷的脂质体(EYPG/EYPG;7:3,w/w)。它们对带负电荷磷脂的高选择性与它们的高细菌选择性非常吻合。吲哚杀菌素在10微摩尔浓度下能使金黄色葡萄球菌的细胞质膜几乎完全去极化,并导致带负电荷脂质体的染料泄漏,而所有富含脯氨酸的模型肽即使在80微摩尔浓度下在这些测定中也几乎没有活性,就像蛙皮素2中观察到的那样。这些结果表明,我们设计的富含脯氨酸的模型肽的最终靶点可能是细胞内成分(如蛋白质、DNA或RNA)而不是细胞质膜。总的来说,我们设计的富含脯氨酸的短模型肽似乎是未来作为新型抗菌剂开发的优秀候选物。